Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
glucidolipids of Salmonella typhi
- Development stage
- Unknown
- Lead developer
- Instituto Biológico Argentino
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Oral
01
Overview
Inespecin is an orally administered immunomodulator containing glucidolipids (glycolipids) of Salmonella typhi. Developed and marketed by Instituto Biológico Argentino (BIOL), it is approved in Argentina and other Latin American countries for the prophylaxis of infectious processes through the non-specific stimulation of organic defenses. Inespecin acts by stimulating the immune system, increasing properdin and complement levels, and activating human mononuclear cells to differentiate into activated macrophages, thereby enhancing the body's innate immune response against pathogens.
- Brand names
- Inespecin
- Other names
- glucidolipidos de Salmonella typhiglucidolípidos de Salmonella typhiglucoproteinas de enterobacteriasglucoproteínas de enterobacterias
02
Targets
PRR (Pattern recognition receptors)
Beyond the preview
Go deeper on glucidolipids of Salmonella typhi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on glucidolipids of Salmonella typhi.